Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | JAK1 | P23458 | 1/20 | 0.38 |
| ▸ | JAK3 | P52333 | 1/20 | 0.38 |
| ▸ | PSMB5 | P28074 | 4/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.37 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.37 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL119773 | 0.97 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4ACMSD | |
| SCHEMBL11201526 | 0.97 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4ACMSD | |
| SCHEMBL18244172 | 0.97 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4ACMSD | |
| SCHEMBL3233355 | 0.97 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4ACMSD | |
| SCHEMBL2105114 | 0.97 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4ACMSD | |
| SCHEMBL3233362 | 0.97 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4ACMSD | |
| SCHEMBL18244171 | 0.97 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4ACMSD | |
| SCHEMBL3502363 | 0.97 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4ACMSD | |
| SCHEMBL21057468 | 0.97 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4ACMSD | |
| SCHEMBL3796623 | 0.97 | TYMP (0.41) | TYMPTDP1ALDH1A1CYP3A4ACMSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 716 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6432995-B1 | — | — | None | — | — | US | claimed |
| US-20260035384-A1 | COMPOUND CONTAINING CYCLOHEXYL | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) | 2026-02-05 | — | — | US | claimed |
| CN-120192323-A | Pyrrolidone-containing compounds | 正大天晴药业集团股份有限公司 | 2025-06-24 | — | — | CN | claimed |
| US-20250152719-A1 | FUSED IMIDE DERIVATIVE | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2025-05-15 | — | — | US | claimed |
| CN-119823111-A | Condensed imide derivative | 正大天晴药业集团股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119731182-A | Cyclohexyl containing compounds | 正大天晴药业集团股份有限公司 | 2025-03-28 | — | — | CN | claimed |
| WO-2025040147-A1 | CYCLOBUTYL-CONTAINING COMPOUNDS | 正大天晴药业集团股份有限公司 | 2025-02-27 | — | — | WO | claimed |
| CN-119462663-A | Pyrrolidone-containing compounds | 正大天晴药业集团股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118994163-A | Compounds containing a fused ring structure | 正大天晴药业集团股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-116285709-B | Low-stress bonding adhesive material and preparation method thereof | 黑龙江省科学院石油化学研究院 | 2024-11-22 | — | — | CN | claimed |
| WO-2001004115-A2 | NOVEL PROCESS FOR SYNTHESIS OF HETEROARYL-SUBSTITUTED UREA COMPOUNDS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2001-01-18 | — | — | WO | claimed |
| WO-2000055139-A2 | HETEROCYCLIC UREA AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2000-09-21 | — | — | WO | claimed |
| WO-2000055152-A1 | AROMATIC HETEROCYCLIC COMPOUNDS AS ANTI-INFLAMMATORY AGENTS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2000-09-21 | — | — | WO | claimed |
| WO-2000050425-A1 | POLYCYCLO HETEROCYCLIC DERIVATIVES AS ANTIINFLAMMATORY AGENTS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2000-08-31 | — | — | WO | claimed |
| EP-1028953-A1 | AROMATIC HETEROCYCLIC COMPOUNDS AS ANTI-INFLAMMATORY AGENTS | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2000-08-23 | — | — | EP | claimed |
| WO-2000043384-A1 | AROMATIC HETEROCYCLIC COMPOUNDS AS ANTIINFLAMMATORY AGENTS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2000-07-27 | — | — | WO | claimed |
| US-6080763-A | INHIBIT THE RELEASE OF INFLAMMATORY CYTOKINES, E.G., TUMOR NECROSIS FACTOR AND INTERLEUKIN-1; USEFUL TO TREAT CHRONIC INFLAMMATORY DISEASE; AUTOIMMUNE DISEASES, E.G. RHEUMATOID ARTHRITIS, OSTEOPOROSIS; PYRAZOLYLUREAS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2000-06-27 | — | — | US | claimed |
| WO-1999023091-A1 | AROMATIC HETEROCYCLIC COMPOUNDS AS ANTI-INFLAMMATORY AGENTS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1999-05-14 | — | — | WO | claimed |
| WO-1994012029-A1 | USE OF FUSED RING CYCLOPENTANONES AND CYCLOPENTENONES IN CONTROLLING PLANT GROWTH | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1994-06-09 | — | — | WO | claimed |
| US-4247711-A | CHEMICAL INTERMEDIATES FOR PYRETHRUM PESTICIDES | SHELL OIL COMPANY (US) | 1981-01-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035384-A1 | COMPOUND CONTAINING CYCLOHEXYL | CYP11B1, CYP4A11, CYP11B2 | TYMP 2718/4885TDP1 4504/4885ALDH1A1 344/4885 |
| US-20250152719-A1 | FUSED IMIDE DERIVATIVE | WEE1, WEE2, CYP4F11 | TYMP 496/4885TDP1 2817/4885ALDH1A1 634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.